End-of-day quote
Other stock markets
|
||
- USD | - |
05-08 | Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M | MT |
Chart calendar Chromadex Corp
Upcoming events on Chromadex Corp
Past events on Chromadex Corp
08/05/2024 21:30 | Q1 2024 Earnings Call |
08/05/2024 21:02 | Q1 2024 Earnings Release |
18/03/2024 23:00 | Roth Conference |
06/03/2024 21:30 | Q4 2023 Earnings Call |
06/03/2024 21:02 | Q4 2023 Earnings Release |
12/02/2024 19:00 | Non-Deal Roadshow - Renmark |
31/01/2024 | Lytham Partners Investor Select Conference |
14/11/2023 19:00 | Non-Deal Roadshow - Renmark |
08/11/2023 21:30 | Q3 2023 Earnings Call |
08/11/2023 21:02 | Q3 2023 Earnings Release |
16/08/2023 19:00 | Non-Deal Roadshow - Renmark |
14/08/2023 17:00 | Non-Deal Roadshow - Renmark |
09/08/2023 21:30 | Q2 2023 Earnings Call |
09/08/2023 21:02 | Q2 2023 Earnings Release |
15/06/2023 23:00 | Annual General Meeting |
06/06/2023 21:30 | LD Micro Invitational Conference |
17/05/2023 | Lytham Partners Spring Investor Conference |
10/05/2023 21:30 | Q1 2023 Earnings Call |
10/05/2023 21:02 | Q1 2023 Earnings Release |
13/03/2023 18:00 | ROTH Conference - Fireside Chat |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 46,3 46,1 0.39% | 59,3 59,1 0.26% | 67,4 68,4 -1.42% | 72,1 72,1 -0.05% | 83,6 83,1 0.53% | 96,6 |
EBITDA Million USD | Released Forecast Spread | -20,2 -22,3 9.51% | -9,62 -10,1 4.78% | -18,9 -19,8 4.36% | -9,97 -9,16 -8.89% | 1,90 0,67 183.58% | 4,17 |
EBIT Million USD | Released Forecast Spread | -31,3 -29,2 -7.32% | -19,9 -19,5 -1.84% | -27,1 -28,3 4.36% | -18,6 -18,9 1.68% | -5,60 -7,11 21.29% | -2,23 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,1 -30,4 -5.67% | -19,9 -19,7 -0.91% | -27,1 -28,6 5.11% | -16,5 -17,4 5.03% | -4,94 -7,07 30.15% | -1,36 |
Net income Million USD | Released Forecast Spread | -32,1 -30,1 -6.95% | -19,9 -19,6 -1.64% | -27,1 -28,6 5.12% | -16,5 -17,3 4.4% | -4,94 -6,62 25.4% | -1,91 |
EPS USD | Released Forecast Spread | -0,56 -0,53 -6.67% | -0,33 -0,32 -3.77% | -0,40 -0,43 6.04% | -0,24 -0,23 -3.07% | -0,07 -0,09 20.45% | -0,01 |
Announcement Date | 10/03/20 | 10/03/21 | 09/03/22 | 08/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 17,8 18,8 -5.38% | 17,3 17,5 -1.51% | 16,7 18,9 -11.43% | 17,1 18,7 -8.94% | 21,0 20,9 0.58% | 22,6 19,3 16.74% | 20,3 19,5 4.1% | 19,5 20,4 -4.3% | 21,2 20,7 2.18% | 22,2 23,6 -6.17% | 23,5 | 24,7 | 26,2 | 26,3 |
EBITDA Million USD | Released Forecast Spread | -3,45 -4,29 19.68% | -4,47 -3,81 -17.58% | -4,64 -3,24 -43.36% | -1,21 -1,39 13.51% | 0,35 0,53 -33.8% | -0,07 -0,94 92.7% | 0,22 -0,60 136.41% | 0,50 -0,29 271.24% | 1,25 0,05 2671.11% | 0,07 | -0,13 | 1,55 | 2,12 | 1,95 |
EBIT Million USD | Released Forecast Spread | -5,32 -6,63 19.84% | -7,73 -5,88 -31.48% | -6,39 -5,74 -11.24% | -3,07 -4,26 28.1% | -1,44 -1,76 17.99% | -1,97 -3,45 42.96% | -2,32 -3,15 26.39% | -1,15 -2,36 51.49% | -0,17 -1,70 90.09% | -0,73 -1,74 58.05% | -1,87 | -0,08 | 0,43 | 0,12 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,33 -6,99 23.8% | -7,74 -6,41 -20.75% | -6,40 -5,87 -9% | -0,99 -3,98 75.25% | -1,42 -1,78 20.25% | -1,90 -3,56 46.56% | -2,19 -2,97 26.14% | -0,96 -2,17 55.75% | 0,11 -2,02 105.65% | -0,49 -1,71 71.17% | -1,83 | 0,24 | 0,70 | -0,20 |
Net income Million USD | Released Forecast Spread | -5,33 -6,92 23.09% | -7,74 -6,13 -26.27% | -6,40 -5,91 -8.3% | -0,99 -4,37 77.47% | -1,42 -1,84 22.75% | -1,90 -3,56 46.58% | -2,19 -3,20 31.43% | -0,96 -2,40 60.12% | 0,11 -1,57 107.27% | -0,49 -1,55 68.31% | -1,60 | -0,15 | 0,39 | 0,37 |
EPS USD | Released Forecast Spread | -0,08 -0,10 22.22% | -0,11 -0,09 -24.53% | -0,09 -0,09 -5.01% | -0,01 -0,06 84.45% | -0,02 -0,03 22.21% | -0,03 -0,05 37.5% | -0,03 -0,04 28.01% | -0,10 -0,03 -215.76% | 0,00 -0,02 - | -0,01 -0,01 16.67% | -0,01 | 0,00 | 0,01 | 0,01 |
Announcement Date | 09/03/22 | 12/05/22 | 10/08/22 | 02/11/22 | 08/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 06/03/24 | 08/05/24 | - | - | - | - |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
Past sector events for Chromadex Corp
Today | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
14/05/2024 06:50 | BELITE BIO, INC: Q1 2024 Earnings Release |
13/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
13/05/2024 21:30 | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 12:00 | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
13/05/2024 00:00 | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
13/05/2024 11:30 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- CDXC Stock
- CDXC Stock
- Calendar Chromadex Corp